Emkay Global maintains a 'Buy' rating on Sun Pharma after the US Court of Appeals vacates the injunction against Leqselvi's ...

After a legal decision delayed its entry last fall, Sun Pharma has received the all-clear to tap into the U.S. | After Sun ...

The rise in the Sun Pharma share price came after a favourable ruling from a US court regarding its planned launch of ...

Leqselvi, part of Sun’s dermatology portfolio, was previously blocked from launch by a court order in November 2024.

Sun Pharmaceuticals is one of India’s largest pharmaceutical companies with over 8% share in the domestic market. It owns 35 ...

Sun Pharmaceutical Industries Ltd. closed 14.89% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

Dilip Shanghvi had said in February that the judgment was crucial for Sun Pharma's future course of action on this drug ...

On Thursday, April 10, Sun Pharma announced that the U.S. Court of Appeals for the Federal Circuit has vacated a preliminary ...

Art Garfunkel is breaking the sound of silence around his experience with plaque psoriasis. | Art Garfunkel is breaking the ...

Sun Pharmaceutical Industries Ltd. closed 13.91% short of its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

March 10, 2025 India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics , a U.S.-based ...

Indian pharma players have been witnessing reprieve from price erosion and US product launches in the past few quarters. A ...